BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $101,000 | -34.4% | 7,423 | -3.9% | 0.00% | – |
| Q3 2016 | $154,000 | +87.8% | 7,726 | +21.8% | 0.00% | – |
| Q2 2016 | $82,000 | +256.5% | 6,342 | +154.1% | 0.00% | – |
| Q1 2016 | $23,000 | -43.9% | 2,496 | +23.4% | 0.00% | – |
| Q4 2015 | $41,000 | -25.5% | 2,023 | -46.5% | 0.00% | – |
| Q3 2015 | $55,000 | -39.6% | 3,783 | -11.8% | 0.00% | – |
| Q2 2015 | $91,000 | +2.2% | 4,289 | +11.2% | 0.00% | – |
| Q1 2015 | $89,000 | – | 3,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
| Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
| Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
| MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
| QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
| KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
| Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
| Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
| First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |